SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061976
Filing Date
2023-11-09
Accepted
2023-11-09 16:00:26
Documents
72
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q meip-20230930.htm   iXBRL 10-Q 1293175
2 EX-31.1 meip-ex31_1.htm EX-31.1 17296
3 EX-31.2 meip-ex31_2.htm EX-31.2 17160
4 EX-32.1 meip-ex32_1.htm EX-32.1 9866
5 GRAPHIC img104063219_0.jpg GRAPHIC 54071
6 GRAPHIC img104063219_1.jpg GRAPHIC 190025
7 GRAPHIC img104063219_2.jpg GRAPHIC 94371
  Complete submission text file 0000950170-23-061976.txt   7135035

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT meip-20230930.xsd EX-101.SCH 47925
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT meip-20230930_pre.xml EX-101.PRE 335449
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT meip-20230930_lab.xml EX-101.LAB 419268
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT meip-20230930_def.xml EX-101.DEF 261341
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT meip-20230930_cal.xml EX-101.CAL 36583
66 EXTRACTED XBRL INSTANCE DOCUMENT meip-20230930_htm.xml XML 1048034
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-41827 | Film No.: 231392113
SIC: 2834 Pharmaceutical Preparations